Related references
Note: Only part of the references are listed.A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung
Zhanhong Xie et al.
MODERN PATHOLOGY (2020)
Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review
Yan Hu et al.
ONCOTARGETS AND THERAPY (2020)
Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature
Zhengwu Tang et al.
LUNG CANCER (2020)
Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden
Qian Wu et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus-Positive and -Negative Relapsed or Refractory Non-Hodgkin Lymphomas
Seok-Jin Kim et al.
CANCER RESEARCH AND TREATMENT (2019)
Pulmonary Lymphoepithelioma-like Carcinoma
Sakda Sathirareuangchai et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes
Hyo Jeong Kang et al.
JOURNAL OF HEPATOLOGY (2019)
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Shaodong Hong et al.
NATURE COMMUNICATIONS (2019)
First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
Zuan Lin et al.
LUNG CANCER (2019)
Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably To Nivolumab: A Case Report
Zhi-Xin Qiu et al.
ONCOTARGETS AND THERAPY (2019)
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade
Anand Narayanan et al.
CLINICAL LUNG CANCER (2019)
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases
Yinyin Qin et al.
CLINICAL LUNG CANCER (2019)
Immunotherapy for LELC: Case Report and a Focused Review
Marie Darrason et al.
CLINICAL LUNG CANCER (2019)
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore
Chee Kiang Tay et al.
ANNALS OF THORACIC MEDICINE (2018)
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients
Mian Xie et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Correlation and prognostic significance of PD-L1 and P53 expression in resected primary pulmonary lymphoepithelioma-like carcinoma
Xiang-Yang Yu et al.
JOURNAL OF THORACIC DISEASE (2018)
Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab
Vivek Kumar et al.
IMMUNOTHERAPY (2017)
Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome
Chun-Yu Lin et al.
JOURNAL OF THORACIC DISEASE (2017)
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature
Chul Kim et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
Yih-Leong Chang et al.
LUNG CANCER (2015)
Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung
Qianwen Liu et al.
THORACIC CANCER (2014)
Multimodality Treatment and Long-Term Follow-Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma
Chung-Jen Huang et al.
CLINICAL LUNG CANCER (2012)
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
Yih-Leong Chang et al.
CANCER SCIENCE (2011)
Lymphoepithelioma-like carcinoma of the lung
James C. Ho et al.
RESPIROLOGY (2006)
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas
YL Chang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Share Paper
